Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
DE ›
DEGRONIMID
Trademark search for:
DEGRONIMID
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-11-18 — Application filed
2015-11-21 — Application filed
2015-11-23 — Application filed
2016-03-10 — Assigned to examiner
2016-03-11 — Approved for pub - principal register
2016-04-06 — Notification of notice of publication e-mailed
2016-04-26 — Published for opposition
2016-04-26 — Official gazette publication confirmation e-mailed
2016-06-21 — Noa e-mailed - sou required from applicant
2016-11-30 — Teas revoke/app/change addr of atty/dom rep received
2016-11-30 — Attorney/dom.rep.revoked and/or appointed
2016-12-05 — Sou teas extension received
2016-12-05 — Sou extension 1 filed
2016-12-05 — Sou extension 1 granted
2016-12-07 — Notice of approval of extension request e-mailed
2017-04-27 — Sou teas extension received
2017-04-27 — Sou extension 2 filed
2017-04-27 — Sou extension 2 granted
2017-04-29 — Notice of approval of extension request e-mailed
2017-12-07 — Teas change of owner address received
2017-12-07 — Applicant/correspondence changes (non-responsive) entered
2017-12-12 — Sou teas extension received
2017-12-12 — Sou extension 3 filed
2017-12-12 — Sou extension 3 granted
2017-12-14 — Notice of approval of extension request e-mailed
2018-05-25 — Sou teas extension received
2018-05-25 — Sou extension 4 filed
2018-05-25 — Sou extension 4 granted
2018-05-29 — Notice of approval of extension request e-mailed
2018-12-05 — Sou teas extension received
2018-12-05 — Sou extension 5 filed
2018-12-13 — Case assigned to intent to use paralegal
2018-12-13 — Sou extension 5 granted
2018-12-14 — Notice of approval of extension request e-mailed
2019-07-22 — Application abandoned
2019-07-22 — Application abandoned
2019-07-22 — Final status recorded
Owner Information
C4 Therapeutics, Inc.
C4 Therapeutics, Inc.
Correspondent
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
